NutriBand (NTRB) Accumulated Expenses (2020 - 2024)
NutriBand's (NTRB) quarterly Accumulated Expenses came in at $1.0 million in Q1 2024, up 197.11% quarter-over-quarter from $345565.0 in Q4 2020.
NutriBand (NTRB) Accumulated Expenses (2020 - 2024) Analysis & Trends
NutriBand has disclosed Accumulated Expenses across 2 years of filings, most recently posting $1.0 million for Q1 2024.
- Accumulated Expenses for Q1 2024 came in at $1.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2024 was $1.0 million (changed N/A YoY), and the FY2024 annual result was $1.0 million, changed N/A from the prior year.
- Accumulated Expenses came in at $1.0 million for Q1 2024 at NutriBand, up from $345565.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.0 million in Q1 2024 to a low of $345565.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2024 | 1.03 Mn |
| Oct 31, 2020 | 345,565.00 |